Get the Daily Brief
Latest Biotech News
FDA Regulatory Challenges and Controversies Surrounding Duchenne Muscular Dystrophy Therapies
Recent regulatory disruptions at the FDA have surfaced amid scrutiny of Duchenne muscular dystrophy (DMD) gene therapy approvals. Sarepta Therapeutics experienced sudden FDA holds and shipment...
Advances in AI and Deep Learning for Medical Diagnostics and Drug Development
Artificial intelligence and deep learning techniques are rapidly transforming diagnostics and pharmaceutical workflows. Recent breakthroughs include a deep learning model accurately predicting...
Breakthroughs in Cancer Therapies and Biomarkers Across Multiple Tumor Types
Innovations in cancer treatment and biomarker discovery continue to reshape precision oncology. Recent key advances include identification of novel inhibitors targeting KRAS G12D/V mutants and...
Innovative Immunotherapy and Neuroplasticity Findings
Emerging research reveals new dimensions of immune regulation and neuroplasticity relevant for cancer and neurological diseases. Key studies identify lactate signaling as a driver of...
Breakthroughs in Imaging and Microscopy Technologies
Recent technological advances are driving unprecedented capabilities in biomedical imaging and microscopy. Innovations include a chip-based optical system delivering super-resolution microscopy...
Gene Therapy and Cell Therapy Manufacturing Scale-Up Challenges
The gene therapy field faces critical hurdles in scaling manufacturing to meet growing patient demands for complex viral vectors. Conventional 200-liter bioreactors are insufficient for the rising...
Biotech Market Dynamics: Venture Funding and Regional Challenges
Despite a challenging equity landscape for biotech in 2025, several investors continue to amass significant capital focused on healthcare innovation. OrbiMed raised $1.86 billion for its fifth...
FDA and Regulatory Events Affecting Biotech Companies and Industry Outlook
The biotech regulatory environment experiences turbulence with leadership shifts and controversial AI adoption. The recent FDA departure of Vinayak Prasad, center for biologics evaluation and...
Bruker Shares Dive on Disappointing Q2 Revenues and Lowered Guidance
Bruker Corporation experienced a sharp 14% drop in stock price after reporting Q2 revenues of $797.4 million, below Wall Street’s expected $810.2 million. The company cited a 7% year-over-year...
FDA Cancer Regulator’s Role in Replimune Therapy Rejection
Internal sources revealed that FDA's top cancer drug regulator intervened late in the review process of Replimune’s melanoma therapy RP1, significantly influencing its final rejection despite...
Roche Gains FDA Clearance for Multiplex Respiratory Virus Test
Roche Diagnostics secured FDA clearance for its Cobas Respiratory 4-flex assay, which simultaneously detects SARS-CoV-2, influenza A/B, and RSV on high-throughput Cobas platforms. The test employs...
Waters Beats Q2 Targets, Raises Outlook After Pharma Market Growth
Waters Corporation outperformed Q2 revenue estimates, driven by strong sales to the pharmaceutical sector, and subsequently raised its full-year guidance. The company's recent announcement to...
Psychedelic Analogs Promote Neuroplasticity Without Hallucinations
Researchers have delineated that non-hallucinogenic psychedelic analogs like tabernanthalog (TBG) induce neuroplasticity through the same receptor pathways as classical psychedelics (5-MeO-DMT)...
Microplastic Pollution and Human Health: Emerging Evidence
A series of studies published in Microplastics & Nanoplastics highlight the widespread presence of microplastics and nanoplastics in diverse environments and human systems, including detection in...
Gene Therapy Manufacturing Faces Scale-Up Challenges
As gene therapies target larger patient populations, scaling manufacturing to 1,000 liters plus bioreactors confronts significant obstacles, particularly in maintaining transfection complex...
Xoma Acquires Struggling Biotechs Following Clinical Setbacks
Xoma Royalty has acquired HilleVax and Lava Therapeutics, two biotechs that recently suffered clinical trial failures and workforce reductions. HilleVax’s norovirus vaccine failed phase 2b...
Leukemia Cutis Therapy: Azelaic Acid Blocks Skin Cell Trafficking
Researchers have identified azelaic acid as a potential therapeutic agent against leukemia cutis by inhibiting the trafficking of acute myeloid leukemia cells to the skin. The study uncovers...
Eli Lilly Sells NJ Facility to Pivot Towards Advanced Biologics
Eli Lilly and Company announced plans to sell its monoclonal antibody manufacturing site in New Jersey as part of a strategic shift focusing on advanced biologics. The divestiture aligns with...
FDA Leadership Shakeup Shakes Cell and Gene Therapy Stocks
The sudden departure of Vinayak Prasad as director of the FDA's Center for Biologics Evaluation and Research has sent ripples through the cell and gene therapy (CGT) sector. Prasad's tenure,...
Microplastics in Human and Environmental Health: New Analytical Insights
Recent studies have intensified scrutiny on micro- and nanoplastics, revealing their infiltration into human blood and terrestrial ecosystems. Researchers have responded to critiques of micro- and...